Elevated TGF-β1 expression levels are found in synovial fibroblasts of RA patients and a blockade of the multifunctional cytokine has been proposed as an experimental RA treatment approach (Pohlers et al., 2007; Sakuma et al., 2007). The gene discussed is TGFB1; the disease is rheumatoid arthritis.